FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

LCX CHLAMYDIA TRACHOMATIS ASSAY

K Number: K934622 · Decision Dec 8, 1995
Classifications
1
FEI Numbers
22
Registration Numbers
22
Same Product Code
18
Applicant Total
883
Review Days
802

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
LCX CHLAMYDIA TRACHOMATIS ASSAY
K Number
K934622
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
866.3120
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Abbott Laboratories
Date Received
September 27, 1993
Decision Date
December 8, 1995
Product Code
MKZ
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MKZ Dna Probe, Nucleic Acid Amplification, Chlamydia

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MKZ), ordered by most recent decision date.

View all

Other Clearances by Abbott Laboratories

K Number Device Name
K252424 Anti-HCV Next
K243500 ARCHITECT iGentamicin
K243168 Alinity i Rubella IgG
K243283 Alinity h-series System
K233932 Alinity i Toxo IgM
K232669 TBI
K222850 HAVAb IgG II
K220031 Alinity h-series System
K220282 i-STAT PTplus Cartridge with the i-STAT 1 System
K230937 Alinity i Total ß-hCG Reagent Kit, GLP systems Track
Search all 883 clearances from Abbott Laboratories →